George D. Hartman

9.8k total citations
183 papers, 5.4k citations indexed

About

George D. Hartman is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, George D. Hartman has authored 183 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 52 papers in Organic Chemistry and 38 papers in Oncology. Recurrent topics in George D. Hartman's work include Platelet Disorders and Treatments (23 papers), Synthesis and Biological Evaluation (20 papers) and Cell Adhesion Molecules Research (19 papers). George D. Hartman is often cited by papers focused on Platelet Disorders and Treatments (23 papers), Synthesis and Biological Evaluation (20 papers) and Cell Adhesion Molecules Research (19 papers). George D. Hartman collaborates with scholars based in United States, Belgium and Canada. George D. Hartman's co-authors include Mark E. Duggan, Wasyl Halczenko, Hans E. Huber, Craig W. Lindsley, Mark T. Bilodeau, R. Robinson, Deborah Defeo-Jones, Melissa S. Egbertson, Zhijian Zhao and Stanley F. Barnett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

George D. Hartman

183 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George D. Hartman United States 40 2.5k 1.7k 600 575 529 183 5.4k
Akira Otaka Japan 50 4.6k 1.8× 2.6k 1.5× 693 1.2× 178 0.3× 537 1.0× 225 7.9k
Alexander J. Bridges United States 27 4.2k 1.6× 2.0k 1.2× 401 0.7× 158 0.3× 246 0.5× 62 7.1k
Vincent Dive France 45 3.0k 1.2× 1.1k 0.7× 488 0.8× 203 0.4× 164 0.3× 140 5.4k
Gÿorgý Kéri Hungary 41 3.5k 1.4× 592 0.3× 388 0.6× 540 0.9× 81 0.2× 162 6.1k
Jenny Bain United Kingdom 25 5.5k 2.2× 683 0.4× 413 0.7× 467 0.8× 126 0.2× 29 7.4k
Pramod S. Pandey United States 43 5.3k 2.1× 673 0.4× 237 0.4× 346 0.6× 138 0.3× 95 7.2k
Juan Marugán United States 42 2.5k 1.0× 716 0.4× 519 0.9× 900 1.6× 86 0.2× 167 5.7k
Wim J. van Blitterswijk Netherlands 51 5.7k 2.3× 415 0.2× 328 0.5× 357 0.6× 128 0.2× 111 7.4k
Luciana Marinelli Italy 43 3.1k 1.2× 1.2k 0.7× 294 0.5× 164 0.3× 711 1.3× 164 5.1k
Julian A. Simon United States 38 3.3k 1.3× 489 0.3× 280 0.5× 485 0.8× 105 0.2× 76 5.7k

Countries citing papers authored by George D. Hartman

Since Specialization
Citations

This map shows the geographic impact of George D. Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George D. Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George D. Hartman more than expected).

Fields of papers citing papers by George D. Hartman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George D. Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George D. Hartman. The network helps show where George D. Hartman may publish in the future.

Co-authorship network of co-authors of George D. Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of George D. Hartman. A scholar is included among the top collaborators of George D. Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George D. Hartman. George D. Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuen, Man‐Fung, Edward Gane, Dong Joon Kim, et al.. (2019). Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection. Gastroenterology. 156(5). 1392–1403.e7. 117 indexed citations
2.
Klumpp, Klaus, Angela M. Lam, Christine Lukacs, et al.. (2015). High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein. Proceedings of the National Academy of Sciences. 112(49). 15196–15201. 122 indexed citations
3.
Kuduk, Scott D., Ronald K. Chang, Christina N. Di Marco, et al.. (2011). Identification of non-amidine inhibitors of acid-sensing ion channel-3 (ASIC3). Bioorganic & Medicinal Chemistry Letters. 21(14). 4255–4258. 16 indexed citations
4.
Brnardic, Edward J., Mark E. Fraley, R. M. Garbaccio, et al.. (2010). 3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts. Bioorganic & Medicinal Chemistry Letters. 20(10). 3129–3133. 30 indexed citations
5.
Coleman, Paul J., John D. Schreier, Georgia B. McGaughey, et al.. (2010). Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(7). 2311–2315. 12 indexed citations
6.
Wolkenberg, S. E., Zhijian Zhao, David D. Wisnoski, et al.. (2009). Discovery of GlyT1 inhibitors with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 19(5). 1492–1495. 15 indexed citations
7.
Zhao, Zhijian, William Leister, Julie A. O’Brien, et al.. (2009). Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(5). 1488–1491. 16 indexed citations
8.
Zhao, Zhijian, R. Robinson, Stanley F. Barnett, et al.. (2007). Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity. Bioorganic & Medicinal Chemistry Letters. 18(1). 49–53. 38 indexed citations
9.
Zhao, Zhijian, Julie A. O’Brien, Wei Lemaire, et al.. (2006). Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides. Bioorganic & Medicinal Chemistry Letters. 16(23). 5968–5972. 12 indexed citations
10.
Zhao, Zhijian, William Leister, R. Robinson, et al.. (2005). Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(4). 905–909. 125 indexed citations
11.
Fraley, Mark E., George D. Hartman, Carolyn A. Buser, et al.. (2005). Discovery of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP. Cancer Research. 65. 1463–1463. 1 indexed citations
12.
Hartman, George D.. (2005). Editorial [Hot Topic: Novel Cancer Therapeutic Targets (Guest Editor: George Hartman)]. Current Topics in Medicinal Chemistry. 5(2). 107–107. 1 indexed citations
13.
Manley, Peter J., Mark T. Bilodeau, Kathleen Coll, et al.. (2003). 2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(10). 1673–1677. 23 indexed citations
14.
Tucker, Thomas J., Marc Abrams, Carolyn A. Buser, et al.. (2002). The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases. Bioorganic & Medicinal Chemistry Letters. 12(15). 2027–2030. 13 indexed citations
15.
Bergman, Jeffrey M., Marc Abrams, Joseph P. Davide, et al.. (2001). Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters. 11(11). 1411–1415. 25 indexed citations
16.
17.
DUGGAN, M. E., Adel M. Naylor-Olsen, James J. Perkins, et al.. (1995). ChemInform Abstract: Non‐Peptide Fibrinogen Receptor Antagonists. Part 7. Design and Synthesis of a Potent, Orally Active Fibrinogen Receptor Antagonist.. ChemInform. 26(51). 1 indexed citations
18.
Hartman, George D., Wasyl Halczenko, Robert L. Smith, et al.. (1992). 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogs. Journal of Medicinal Chemistry. 35(21). 3813–3821. 8 indexed citations
19.
Duggan, Mark E., Alfred W. Alberts, R. Bostedor, et al.. (1991). 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 7. Modification of the hexahydronaphthalene moiety of simvastatin: 5-oxygenated and 5-oxa derivatives. Journal of Medicinal Chemistry. 34(8). 2489–2495. 5 indexed citations
20.
Bohrer, S., et al.. (1990). Motion Detection by Correlation and Voting. MPG.PuRe (Max Planck Society). 471–474. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akira Otaka Breakdown of academic impact, for papers by Alexander J. Bridges Breakdown of academic impact, for papers by Vincent Dive Breakdown of academic impact, for papers by Gÿorgý Kéri Breakdown of academic impact, for papers by Jenny Bain Breakdown of academic impact, for papers by Pramod S. Pandey Breakdown of academic impact, for papers by Juan Marugán Breakdown of academic impact, for papers by Wim J. van Blitterswijk Breakdown of academic impact, for papers by Luciana Marinelli Breakdown of academic impact, for papers by Julian A. Simon
Rankless by CCL
2026